MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Spero Therapeutics, Inc. (SPRO)
Spero Therapeutics, Inc. (SPRO)
source: myfinsight.com
Collaboration receivable,
current and non-current...
-$25,359K
Share-based compensation
$1,114K
Operating lease liability
$525K
Non-cash lease cost
$226K
Prepaid expenses and
other current assets
-$195K
Net cash (used in)
provided by operating...
$15,864K
Canceled cashflow
$11,555K
Net decrease in cash
and cash...
$15,864K
Net loss
-$7,203K
Accrued expenses and
other current...
-$2,436K
something is missing
-$946K
Accounts payable
-$476K
Deferred revenue -
related party, current...
-$258K
Income taxes
-$220K
Other receivables
$16K
Back